SC 13D/A

ARCH VENTURE FUND XII, L.P. - NEUMORA THERAPEUTICS -- SCH 13D/A(#1)

Company: Neumora Therapeutics, Inc.
Filed: December 15, 2023
Accession Number: 0001072613-23-000627

View Document ↗ View on SEC.gov ↗